1. Black, J. W.: Ahlquist and the development of beta-adrenoceptor antagonists. Postgrad. Med. J. 52, Suppl.4, 11 (1976).
2. Fleckenstein, A., H. Tritthart, B. Fleckenstein, et al.: A new group of competitive Ca-antagonists (Iproveratril, D600, Prenylamine) with highly potent inhibitory effects on excitation-contraction coupling in mammalian myocardium. Pflügers Arch. ges. Physiol.307, R25 (1969).
3. Fleckenstein, A.: Specific inhibitors and promoters of calcium action in the excitation-contraction coupling of heart muscle and their role in the prevention or production of myocardial lesions. In: Calcium and the Heart (Harris, P., L. Opie, ed). p. 135. (London-New York, Academic, 1970/1971).
4. Fleckenstein, A., H. Tritthart, H. J. Doring, et al.: Bay a 1040 — ein hochaktiver Ca++-antagonistischer Inhibitor der elektro-mechanischen Koppelungs-prozesse im Warmblüter-Myokard. Arzneim.-Forsch.22, 22 (1972).
5. Vater, W., G. Kroneberg, F. Hoffmeister, et al.: Zur Pharmakologie von 4-(2 Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäuredimethylester (Nifedipin, Bay a 1040). Arzneim.-Forsch.22, 1 (1972).